SDKI Inc. published a new report on the Parenteral Nutrition Market-Forecast 2022-2031 on January 25, 2022. The study includes the statistical and analytical approaches needed to grow the parenteral nutrition market. The key industry insights provided in the report provide readers with better ideas about market overviews regarding existing market scenarios. In addition, the report contains a detailed discussion of current and future market trends related to market growth.
The parenteral nutrition market is estimated to reach US $ 17.60 billion by 2031, from a market value of US $ 7.09 billion in 2022, and is expected to grow at a CAGR of 11.6% during the 2022-2031 forecast period. ..
https://www.sdki.jp/press-details/parenteral-nutrition-market/628
Parenteral nutrition (also called complete parenteral nutrition) is a major nutrient (lipids, carbohydrates, etc.) And a sterile solution containing micronutrients (minerals, vitamins, etc.). The solution bypasses the digestive system and is injected directly into the bloodstream via an intravenous infusion pump. Special types of intravenous catheters such as Broviac, Hickman, triple or double lumen catheters are used for this purpose. The growth of this parenteral nutrition market is primarily due to the increasing number of malnutrition cases worldwide. According to the Global Alliance for Improvement Nutrition, more than 2 billion people worldwide suffer from various forms of malnutrition. According to the organization, more than 2.6 million children around the world die each year from adequate malnutrition.
Parenteral nutrition allows individuals to achieve timely and appropriate nutrition. This has led to an increase in the demand for nutrition through parenteral routes as the number of malnourished people increases. It is driving the growth of the parenteral nutrition market during the forecast period. In addition, the aging population and rising prevalence of chronic conditions have contributed to the growth of the parenteral nutrition market during the forecast period. However, potential complications associated with parenteral nutrition, such as intravenous access-related trauma, air embolism, and thrombophlebitis, may curb the growth of the parenteral nutrition market during the forecast period.
Parenteral nutrition market segment
The parenteral nutrition market is divided by nutrient type (parenteral lipid emulsions, carbohydrates, trace elements, single-dose amino acid solutions, and vitamins and minerals) and by region. These segments are further subsegmented based on various factors and consist of some additional information about the market, such as the combined annual growth rate of each segment and subsegment, the market value and volume of the valuation period.
Based on the type of nutrient, the market is divided into parenteral lipid emulsions, carbohydrates, trace elements, single dose amino acid solutions, and vitamins and minerals. The single dose amino acid solution segment accounted for the highest share. In 2017, the segment recorded US $ 1.5 billion and is expected to dominate the parenteral nutrition market during the forecast period. Developing regions such as Asia Pacific and Latin America are target markets for single-dose amino acid solutions. This is due to an increased incidence of protein deficiencies such as kwashiorkor and marasmus.
Regional overview of parenteral nutrition market
https://www.sdki.jp/press-details/parenteral-nutrition-market/628
Parenteral nutrition (also called complete parenteral nutrition) is a major nutrient (lipids, carbohydrates, etc.) And a sterile solution containing micronutrients (minerals, vitamins, etc.). The solution bypasses the digestive system and is injected directly into the bloodstream via an intravenous infusion pump. Special types of intravenous catheters such as Broviac, Hickman, triple or double lumen catheters are used for this purpose. The growth of this parenteral nutrition market is primarily due to the increasing number of malnutrition cases worldwide. According to the Global Alliance for Improvement Nutrition, more than 2 billion people worldwide suffer from various forms of malnutrition. According to the organization, more than 2.6 million children around the world die each year from adequate malnutrition.
Parenteral nutrition allows individuals to achieve timely and appropriate nutrition. This has led to an increase in the demand for nutrition through parenteral routes as the number of malnourished people increases. It is driving the growth of the parenteral nutrition market during the forecast period. In addition, the aging population and rising prevalence of chronic conditions have contributed to the growth of the parenteral nutrition market during the forecast period. However, potential complications associated with parenteral nutrition, such as intravenous access-related trauma, air embolism, and thrombophlebitis, may curb the growth of the parenteral nutrition market during the forecast period.
Parenteral nutrition market segment
The parenteral nutrition market is divided by nutrient type (parenteral lipid emulsions, carbohydrates, trace elements, single-dose amino acid solutions, and vitamins and minerals) and by region. These segments are further subsegmented based on various factors and consist of some additional information about the market, such as the combined annual growth rate of each segment and subsegment, the market value and volume of the valuation period.
Based on the type of nutrient, the market is divided into parenteral lipid emulsions, carbohydrates, trace elements, single dose amino acid solutions, and vitamins and minerals. The single dose amino acid solution segment accounted for the highest share. In 2017, the segment recorded US $ 1.5 billion and is expected to dominate the parenteral nutrition market during the forecast period. Developing regions such as Asia Pacific and Latin America are target markets for single-dose amino acid solutions. This is due to an increased incidence of protein deficiencies such as kwashiorkor and marasmus.
Regional overview of parenteral nutrition market
The parenteral nutrition market is further subdivided based on the region, and the market growth of each country is evaluated. These include North America (US, Canada, and other North America), Europe (Germany, France, Italy, Spain, UK, and other Europe), Asia Pacific (China, Japan, India, Australia, Singapore, and others). Asia Pacific) and other regions.
North America and Europe totaled more than 75% revenue share in 2017. Aggressive strategies adopted by key players to expand their presence in these regions are driving the growth of the parenteral nutrition market. In August 2017, Baxter collaborated with the American Parenteral Enteral Nutrition Society (ASPEN) to raise awareness about the proper use of nutritional therapy. This also contributes to the growth of the parenteral nutrition market. Meanwhile, the Asia Pacific parenteral nutrition market has a revenue share of over 14% in 2017 and is projected to grow at a CAGR of 6.9% during the forecast period.
Key Players
in the Parenteral Nutrition Market Key players in the parenteral nutrition market include Fresenius Kabi AG, B. Braun Melsungen AG, Baxter International, Inc., Pfizer, Inc., and Allergan Plc. The study includes a detailed competitive analysis of these major companies in the parenteral nutrition market, corporate profiles, recent developments, and key market strategies.
Report sample URL
https://www.sdki.jp/sample-request-53278
SDKI Inc. Company profile
SDKI Inc.'s goal is to uncover market scenarios in different countries such as Japan, China, the United States, Canada, the United Kingdom and Germany. We also focus on providing reliable research insights to clients around the world, including growth indicators, challenges, trends and competitive environments, through a diverse network of research analysts and consultants. SDKI has gained trust and a customer base in more than 30 countries and is further focused on expanding its foothold in other pristine economies.
North America and Europe totaled more than 75% revenue share in 2017. Aggressive strategies adopted by key players to expand their presence in these regions are driving the growth of the parenteral nutrition market. In August 2017, Baxter collaborated with the American Parenteral Enteral Nutrition Society (ASPEN) to raise awareness about the proper use of nutritional therapy. This also contributes to the growth of the parenteral nutrition market. Meanwhile, the Asia Pacific parenteral nutrition market has a revenue share of over 14% in 2017 and is projected to grow at a CAGR of 6.9% during the forecast period.
Key Players
in the Parenteral Nutrition Market Key players in the parenteral nutrition market include Fresenius Kabi AG, B. Braun Melsungen AG, Baxter International, Inc., Pfizer, Inc., and Allergan Plc. The study includes a detailed competitive analysis of these major companies in the parenteral nutrition market, corporate profiles, recent developments, and key market strategies.
Report sample URL
https://www.sdki.jp/sample-request-53278
SDKI Inc. Company profile
SDKI Inc.'s goal is to uncover market scenarios in different countries such as Japan, China, the United States, Canada, the United Kingdom and Germany. We also focus on providing reliable research insights to clients around the world, including growth indicators, challenges, trends and competitive environments, through a diverse network of research analysts and consultants. SDKI has gained trust and a customer base in more than 30 countries and is further focused on expanding its foothold in other pristine economies.
